Sexual Dysfunction in Patient’s Diagnosed with Cervical Cancer in Comparison to the Healthy Female Population Authors: Witchapone Dirakwaranon, Komsun Suwannarurk, Yanwadee Chitkoolsamphan, Pattra Wisarnsirirak, Kornkarn Bhamarapravatana, Junya Pattaraarchachai Published: 2024 ABSTRACT AbstractObjective:Aim of the study was to evaluate and compare the prevalence female sexual dysfunction (FSD) in cervical cancer (CC) survivors to a healthy female population. Materials and Methods: This observational prospective trial was conducted at Thammasat University Hospital, Thailand, between April 2023 and February 2024. Participants were CC survival who attended an outpatient cancer clinic. Subject with age between 30 and 60 years old and engaged in sexual intercourse at least once within the last 4 weeks were recruited. The control group was women who attended outpatient gynecologic clinic for routine pelvic examination with no serious medical diseases and no malignancy. The female sexual function index (FSFI) was applied to all the participants during the survey. Other demographic data of the participants were collected. Results:A total of 116 cases were enrolled in the study. Participants were equally divided into the study and control groups. The mean age and BMI of participants were 49.4 years and 24.7 kg/m², respectively without statistical significance. The FSD’s prevalence of the CC survival was significantly higher than control group (34.5 and 10.4 percent, respectively). CC survivors reported significantly poorer outcomes in the domains of lubrication, sexual satisfaction, and pain compared to the control group. Conclusion:The prevalence rates of CC survival and control group was 34.5 and 10.4 percent, respectively. Three out of six FSFI domains namely lubrication, satisfaction, and pain showed more problematic for CC survivors compared to control group. Key Words: Cervical cancer survivors, female sexual dysfunction, FSFI score Introduction Female sexual dysfunction (FSD) was characterized by persistent and recurrent difficulties in initiating and completing one or more phases of the physical sexual response cycle, including desire, arousal, orgasm, and resolution [1]. FSD can affect biological, psychological, behavioral, and sociocultural factors, thereby impacting the quality of life [1, 2]. According to the World Health Organization (WHO), sexuality was a significant factor in determining quality of life. It was linked to thoughts, feelings, actions, social integration, and both physical and mental health, as well as overall well-being [3]. Cervical cancer (CC) ranked as the fourth most commonly diagnosed cancer among women globally, with approximately 570,000 new cases reported in 2018, accounting for 6.6% of all female cancer [4]. In Thailand, CC was still one of the major public health problems with age standardized incidence rate (ASR) at 16.4 per 100,000 in year 2020 [5]. For over two decades, it has been established that human papillomavirus (HPV) infection was a predominant cause of CC in Thailand, responsible for 86–95% of the cases. As a result, only persistent high-risk HPV infections can lead to CC [6]. The global strategy to eliminate cervical cancer focused on three main objectives included widespread vaccination, early screening for eligible women, and treatment for those with positive screening results, which was implemented in Thailand [5]. Excellent result of CC treatment came from surgery from expertise gynecologic oncology surgeon, intensity modulated radiotherapy, effective chemotherapy, agent and targeted therapy [7]. The treatment of CC typically involved either surgery or radiotherapy, both of which can result in FSD. This dysfunction often raised from bilateral oophorectomy or ovarian failure caused by radiation, leading to a sudden onset of menopause. Further bilateral oophorectomy’s complication includes vaginal dryness, dyspareunia, decreased libido, and depression. Additionally, radical hysterectomy or radiation can shorten the vaginal canal, causing anatomical distortions that impact sexual function. Consequently, surgery may lead to dyspareunia, anorgasmia, and body image distortion, all of which contribute to FSD [8]. The quality of life for women who were CC survivors has declined which was impacting their overall health [9-11]. As CC survivors lived longer, the importance of maintaining life satisfaction becomes increasingly important. Generally, female sexual desire was crucial for reproductive health and linked to an enhanced quality of life [12]. This study aimed to evaluate and compare the prevalence FSD in CC survivors to a healthy female population. The results of this research might add some aspect to the improvement of comprehensive patient management strategies which would be beneficial to both the oncological and holistic needs of the patients. Materials and Methods This observational prospective trial was conducted at Thammasat University Hospital, Thailand, between April 2023 and February 2024. The study received approval from the Human Ethics Committee of Thammasat University (MTU-EC-OB-1-067/66). Participants were women diagnosed with CC who attended an outpatient cancer clinic (OPCC) at Thammasat Hospital, Pathumthani, Thailand for disease progression surveillance according to the regular protocol. Inclusion criteria included CC survivors (study group) were between 30 and 60 years old. Additionally, CC survivors who had engaged in sexual intercourse at least once within the last 4 weeks prior to the survey were. Exclusion criteria included participants with language barriers, underlying diseases requiring urgent treatment, namely cardiovascular disease, stroke, psychiatric disorders, illicit drug use, refusal to participate, and those diagnosed with more than one type of cancer. In the control group, women who attended outpatient gynecologic clinic for routine pelvic examination with no serious medical diseases and no malignancy were recruited. The sample size was calculated based on the Dandamrongrak study from 2021 [8]. The prevalence of FSD among gynecologic cancer survivors was 53 percent (52/98). Type 1 and Type 2 errors were set at levels of 5 and 10 percent, respectively. The number of subjects required for statistical significance were 96 cases. An additional 20 percent was added to compensate for potential data loss, resulting in a sample size of 120 cases for this study. The participants were classified into two groups including the study and control groups. Each initially consisted of 60 participants. Before recruitment, participants were informed about the study process. This questioning process was conducted privately and only the investigator and the participant were present. Participants were informed that they could ask any questions about the questionnaire at any time during the process. Following a comprehensive explanation of the study, informed consent was obtained from each participant. Upon receiving consent, each participant was provided with a questionnaire consisting of four sections. Participants who were uncomfortable with any aspect of the study were allowed to withdraw at any point. The demographic data of the participants were collected in the first part of the questionnaire. Obstetric and gynecologic history of the participants were presented in the second part. The third part included a Thai translation the female sexual function index (FSFI), which consists of 19 self-administered instrument items that assess six domains of sexual function [13]. The six domains of female function for sexually active encompassing desire, arousal, lubrication, orgasm, satisfaction, and pain were explored. In each domain, the higher score indicated non-sexual dysfunction. The fourth part evaluated participant satisfaction before and after the completion of the questionnaire. Each question scored on a scale from 0 to 5. The FSFI scores ranged from 2 to 36. The score of less than 26 on the FSFI indicated FSD, providing a sensitivity of 0.77 and specificity of 0.85 for detecting clinical diagnoses of FSD [14]. Data analysis was divided into categorical and continuous data. The categorical data results were presented as n (%), while the continuous data results were shown as mean ± standard deviation. Group comparisons for categorical data were conducted using the chi-square test or Fisher’s exact test. In contrast, group comparisons for continuous data were performed using an independent t-test. The data were analyzed using the Statistical Package for the Social Sciences (SPSS) version 23 (SPSS Inc., Chicago, USA). A p-value less than 0.05 was considered statistically significant. Results A total of 116 cases were enrolled in the study. Participants were equally divided into the study and control groups as shown in Figure 1. The mean age and BMI of participants were 49.4 years and 24.7 kg/m², respectively without statistical significance. The total number of government officers among the control group (46.6%, 27/58) was statistically higher than that in the study group (17.2%, 10/58), p-value < 0.01. Most participants were Buddhism (116/118). Half of the participants (59/116) had an educational level of a bachelor’s degree or higher, which was not statistically significant between both groups. One-fifth (16/58) of the study cases underwent surgical staging surgery without post-operative adjuvant treatment. Demographic characteristics, including underlying disease, religion, and marital status, were comparable between the two groups, as shown in Table 1. Flow Chart of Study. FSFI, female sexual index; Study, cervical cancer survivors Table 1Demographic Characteristics of Cervical Cancer Survivors (study, n=58) and Control (n=58) with the Comparison between FSD and NFSD of Cervical Cancer SurvivalControl*Study*p-valueFSD**NFSD**p-valueAge (years)48.9±6.049.8±8.20.4854.0±4.347.9±7.3<0.001Marital status**48(82.8)50 (86.2)0.86518(69.2)80(88.9)0.015Occupation<0.0010.116GO27 (46.6)10 (17.2)5(19.23)32(35.56)Other31 (53.4)48 (82.8)21(80.77)58(64.44)No UD**29 (50.0)18 (31.0)0.0416(61.54)62(68.89)0.482BMI<2511 (69.0)22 (40.0)0.04211(69.0)22(40.0)0.042≥259 (90.0)16 (45.7)0.0279(90.0)16(45.7)0.027Education0.103